NCT06096272

Brief Summary

Children with cerebral palsy (CP), Gross Motor Functional Classification Scale (GMFCS) I-II will be recruited to participate in a home based physical activity intervention for 4 weeks. Demographic data will be collected, and validated surveys assessing baseline physical activity level and mobility will be completed. Participants will have an exercise program assigned and will be given a logbook to record their exercise adherence. They will be assigned to the Augment Reality (AR) app group. The AR app group will have exercises administered through the AR app. At the end of the program, participants will complete final surveys and an exit interview.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 23, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

June 7, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

January 20, 2025

Status Verified

January 1, 2025

Enrollment Period

12 months

First QC Date

August 28, 2023

Last Update Submit

January 16, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of participants that complete mobile application delivered exercise program.

    Measured by proportion of time in the mobile application (180/360 total minutes).

    Baseline to 4 weeks.

  • Number of participants that complete the standard exercise program.

    Measured by proportion of time (180/360 total minutes) to complete exercises in logbook.

    Baseline to 4 weeks.

Secondary Outcomes (2)

  • Engagement in the mobile application, Gold-Rizzo Immersion and Presence (GRIP) Inventory scale.

    At Week 4.

  • Change in Quality-of-Life measure: Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Activity and Mobility.

    Baseline to 4 weeks.

Study Arms (1)

Augment Therapy app

EXPERIMENTAL

The app will be implemented with the participant's compatible iPad that will be securely integrated with a network-server for real-time data access and storage. If the participant does not have a compatible device, this will be provided by the research team. Participants will be provided an on-site or virtual CHLA tutorial about using the app and set up of the gaming system. Participants will access their home program on the app at least for 20 minutes, 3 times a week over a 4-week period. A coordinator will check in virtually with the participant during the program. They will complete baseline and final surveys. Exercise data will be collected and stored through the Augment Therapy™ app and self log book.

Device: Augment Reality Exergames

Interventions

Adaptive physical activity AR gaming modules were created in collaboration with physical therapists with expertise in CP and the Augment Therapy app development team. The program will consists of 5 games adapted for children with cerebral palsy.

Augment Therapy app

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of cerebral palsy,
  • Ambulatory (GMFCS I and II)
  • English or Spanish speaking
  • No plans for lower extremity surgery in the next 4 months

You may not qualify if:

  • Moderate to severe developmental or cognitive delay
  • Significant hearing loss or visual impairment
  • Recent surgical procedure or fracture over the past 4 months that impacts physical activity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jackie and Gene Autry Orthopedic Center, CHLA

Los Angeles, California, 90027, United States

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyCell Phone UsePrecursor Cell Lymphoblastic Leukemia-LymphomaSedentary Behavior

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCommunicationBehaviorSocial BehaviorLeukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Melissa Bent, MD

    Children's Hospital Los Angeles

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abigail Padilla, BS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 28, 2023

First Posted

October 23, 2023

Study Start

June 7, 2024

Primary Completion

May 31, 2025

Study Completion

September 1, 2025

Last Updated

January 20, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations